The Commission is now operating in accordance with the Caretaker ConventionsExternal link pending the outcome of the 2025 federal election.
The Acute Anaphylaxis Clinical Care Standard will help to ensure that Australians receive prompt treatment to manage severe allergic reactions, and that there is continuity of patient care across healthcare settings.
This infographic outlines key data highlights on anaphylaxis in Australia, to support the release of the new standard on 24 November 2021.
An example of data used in the Antimicrobial Stewardship Clinical Care Standard Indicator Monitoring Tool.
Antimicrobial Stewardship Clinical Care Standard Indicator Monitoring Tool - template for use by Clinicians and Health Service Organisations.
Quick Reference Guide for the Antimicrobial Stewardship Clinical Care Standard Indicator Monitoring Tool.
This document provides a discussion guide and checklist to ensure patients who have experienced anaphylaxis are safely discharged from care.
Resources related to incident management published by states’ and territories’ are provided below and will be added to over time.
The National Mutual Acceptance (NMA) Scheme for Ethical and Scientific Review of Multi-Centre Research is consistently recognised as a key enabler for clinical trials and research conduct in Australia. All state and territory Public Health Organisations now participate in the scheme facilitated by the Australian Government’s Encouraging More Clinical Trials in Australia measure.
This issue includes items on COVID-19, the launch of the Acute Anaphylaxis Clinical Care Standard, care integration, health information technology, opioid prescribing, gender and sex, and more.
Also covered are the latest issues of Future Leaders Communiqué, Healthcare Papers and Public Health Research & Practice along with the latest online papers from the International Journal for Quality in Health Care and the latest from the UK’s NICE and the USA’s AHRQ.